<DOC>
	<DOC>NCT02856282</DOC>
	<brief_summary>The purpose is to obtain real-world information on how consumers are complying with the product labelling This study will coincide with the launch of Pirinase Hayfever Relief for Adults 0.05% Nasal Spray in the United Kingdom (UK).</brief_summary>
	<brief_title>Drug Utilization Study for Pirinase Hayfever Relief</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis, Allergic, Seasonal</mesh_term>
	<criteria>Participants will be required to review, and electronically sign a Participation Agreement prior to completing the online survey. Participants of any age may participate. Participants who have purchased and used Pirinase Hayfever Relief for Adults 0.05% Nasal Spray for at least 7 days and are willing to participate in the online survey. Participants of either gender may participate Anyone who is directly involved with medicines such as doctors, nurses, and pharmacists. Participants who decline participation in the online survey</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>